Press Release: PSG : Pharmaceutical Strategies Group to Attend, Exhibit at 340B Coalition Winter Conference in San Francisco

PLANO, Texas & SAN FRANCISCO--(BUSINESS WIRE)--Pharmaceutical Strategies Group (PSG), a leader in 340B solutions, will exhibit at the 2015 340B Coalition Winter Conference in San Francisco from Wednesday through Friday (Feb. 4-6). PSG executives will be available to discuss the company's lineup of 340B solutions in booths 14 and 15 during the three-day conference at the Hyatt Regency Embarcadero. "Administrating a 340B program is extremely complex, and PSG can provide a single-stop solution tha

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Dave Borden's photo - CEO of Pharmaceutical Strategies Group, LLC


Dave Borden

CEO Approval Rating


PSG is a provider of benefit consulting and data analytics services to the pharmaceutical sector. Read more